Koninklijke Philips (NYSE:PHG) Upgraded to “Neutral” by BNP Paribas

BNP Paribas upgraded shares of Koninklijke Philips (NYSE:PHG) from an underperform rating to a neutral rating in a research report sent to investors on Tuesday morning, Marketbeat Ratings reports.

Several other research firms have also recently weighed in on PHG. StockNews.com raised shares of Koninklijke Philips from a buy rating to a strong-buy rating in a report on Thursday, February 8th. UBS Group raised Koninklijke Philips from a sell rating to a neutral rating in a report on Tuesday, April 30th. Finally, JPMorgan Chase & Co. raised Koninklijke Philips from an underweight rating to a neutral rating in a report on Tuesday, April 30th. Three equities research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of Moderate Buy and a consensus price target of $19.00.

Koninklijke Philips Price Performance

Shares of NYSE PHG opened at $26.51 on Tuesday. The company has a 50 day moving average of $21.35 and a 200 day moving average of $21.33. The company has a quick ratio of 0.78, a current ratio of 1.20 and a debt-to-equity ratio of 0.58. Koninklijke Philips has a twelve month low of $17.75 and a twelve month high of $29.44. The firm has a market cap of $24.62 billion, a P/E ratio of -27.61, a PEG ratio of 1.39 and a beta of 0.75.

Hedge Funds Weigh In On Koninklijke Philips

Several institutional investors have recently bought and sold shares of PHG. Capital Analysts LLC raised its holdings in shares of Koninklijke Philips by 6.3% in the fourth quarter. Capital Analysts LLC now owns 8,820 shares of the technology company’s stock worth $206,000 after buying an additional 521 shares during the period. Dorsey & Whitney Trust CO LLC raised its holdings in shares of Koninklijke Philips by 5.7% in the fourth quarter. Dorsey & Whitney Trust CO LLC now owns 11,374 shares of the technology company’s stock valued at $265,000 after acquiring an additional 615 shares in the last quarter. Cambridge Investment Research Advisors Inc. lifted its stake in Koninklijke Philips by 3.2% in the third quarter. Cambridge Investment Research Advisors Inc. now owns 22,616 shares of the technology company’s stock worth $451,000 after acquiring an additional 696 shares during the period. Kovitz Investment Group Partners LLC grew its holdings in Koninklijke Philips by 1.7% during the 3rd quarter. Kovitz Investment Group Partners LLC now owns 44,746 shares of the technology company’s stock worth $892,000 after acquiring an additional 750 shares in the last quarter. Finally, Fifth Third Bancorp lifted its position in shares of Koninklijke Philips by 34.4% in the 1st quarter. Fifth Third Bancorp now owns 3,008 shares of the technology company’s stock worth $60,000 after purchasing an additional 770 shares during the period. 13.67% of the stock is owned by hedge funds and other institutional investors.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.